Health
Scientists use new technique to study the effects of reactive electrophilic drugs – News-Medical.net
In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative…
In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that affects millions of people worldwide. In multiple sclerosis, inflammation damages the protective myelin…
Continue Reading
-
Noosa News22 hours agoGrieving Queensland mother demands answers over ‘suspicious’ Bali death of 23-year-old Byron Haddow
-
Noosa News18 hours agoCharacter design compromises in new sets cause controversy among adults
-
General19 hours agoCan Gap Inc.’s Richard Dickson bring back Banana Republic’s relevancy in retail?
-
Noosa News22 hours agoParts of Australia shiver through cold snap as WA prepares for week of storms